Dynamic Medical Technologies Inc. (TPEX:4138)
Taiwan
· Delayed Price · Currency is TWD 56.00
-0.30 (-0.53%)
Apr 29, 2026, 1:30 PM CST
TPEX:4138 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 1,387 | 1,573 | 1,594 | 1,292 | 1,028 | Upgrade
|
| Revenue | 1,387 | 1,573 | 1,594 | 1,292 | 1,028 | Upgrade
|
| Revenue Growth (YoY) | -11.82% | -1.31% | 23.36% | 25.63% | 1.87% | Upgrade
|
| Cost of Revenue | 775.36 | 943.48 | 990.45 | 839.16 | 673.6 | Upgrade
|
| Gross Profit | 611.4 | 629.22 | 603.05 | 452.53 | 354.58 | Upgrade
|
| Selling, General & Admin | 425.79 | 383.28 | 337.43 | 297.04 | 192.89 | Upgrade
|
| Operating Expenses | 421.41 | 384.13 | 334.5 | 294.2 | 194.16 | Upgrade
|
| Operating Income | 189.99 | 245.09 | 268.56 | 158.33 | 160.42 | Upgrade
|
| Interest Expense | - | -1.75 | -0.15 | -1.33 | -0.87 | Upgrade
|
| Interest & Investment Income | 41.54 | 37.62 | 27.75 | 14.11 | 6.98 | Upgrade
|
| Earnings From Equity Investments | -1.44 | 1.05 | 1.05 | -2.6 | 0.86 | Upgrade
|
| Currency Exchange Gain (Loss) | -11.3 | 5.52 | 1.3 | 7 | -0.59 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.79 | -2.79 | -1.22 | 2.64 | 7.04 | Upgrade
|
| EBT Excluding Unusual Items | 218 | 284.73 | 297.29 | 178.16 | 173.82 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0.7 | - | - | - | Upgrade
|
| Other Unusual Items | -0.18 | 4.23 | 0.01 | - | - | Upgrade
|
| Pretax Income | 217.82 | 289.67 | 297.31 | 178.16 | 173.82 | Upgrade
|
| Income Tax Expense | 38.06 | 51.61 | 59.54 | 38.3 | 32.13 | Upgrade
|
| Earnings From Continuing Operations | 179.76 | 238.06 | 237.76 | 139.86 | 141.69 | Upgrade
|
| Minority Interest in Earnings | -27.7 | -32.66 | -27.44 | -2.75 | -18.48 | Upgrade
|
| Net Income | 152.06 | 205.39 | 210.32 | 137.11 | 123.21 | Upgrade
|
| Net Income to Common | 152.06 | 205.39 | 210.32 | 137.11 | 123.21 | Upgrade
|
| Net Income Growth | -25.97% | -2.34% | 53.39% | 11.29% | 6.22% | Upgrade
|
| Shares Outstanding (Basic) | 40 | 40 | 40 | 40 | 40 | Upgrade
|
| Shares Outstanding (Diluted) | 40 | 40 | 40 | 40 | 40 | Upgrade
|
| Shares Change (YoY) | 0.05% | -0.00% | -0.08% | -0.07% | -0.02% | Upgrade
|
| EPS (Basic) | 3.81 | 5.14 | 5.27 | 3.43 | 3.09 | Upgrade
|
| EPS (Diluted) | 3.79 | 5.13 | 5.25 | 3.42 | 3.07 | Upgrade
|
| EPS Growth | -26.12% | -2.20% | 53.31% | 11.34% | 6.23% | Upgrade
|
| Free Cash Flow | 263.06 | 126.94 | 290.43 | 162.88 | 235.37 | Upgrade
|
| Free Cash Flow Per Share | 6.56 | 3.17 | 7.25 | 4.06 | 5.87 | Upgrade
|
| Dividend Per Share | 4.200 | 4.150 | 5.579 | 2.367 | 2.780 | Upgrade
|
| Dividend Growth | 1.21% | -25.61% | 135.72% | -14.87% | 5.72% | Upgrade
|
| Gross Margin | 44.09% | 40.01% | 37.84% | 35.03% | 34.49% | Upgrade
|
| Operating Margin | 13.70% | 15.58% | 16.85% | 12.26% | 15.60% | Upgrade
|
| Profit Margin | 10.96% | 13.06% | 13.20% | 10.62% | 11.98% | Upgrade
|
| Free Cash Flow Margin | 18.97% | 8.07% | 18.23% | 12.61% | 22.89% | Upgrade
|
| EBITDA | 281.94 | 344.8 | 353.33 | 221.05 | 214.53 | Upgrade
|
| EBITDA Margin | 20.33% | 21.92% | 22.17% | 17.11% | 20.87% | Upgrade
|
| D&A For EBITDA | 91.95 | 99.71 | 84.77 | 62.72 | 54.11 | Upgrade
|
| EBIT | 189.99 | 245.09 | 268.56 | 158.33 | 160.42 | Upgrade
|
| EBIT Margin | 13.70% | 15.58% | 16.85% | 12.26% | 15.60% | Upgrade
|
| Effective Tax Rate | 17.47% | 17.82% | 20.03% | 21.50% | 18.49% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.